Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 10:13 PM
Study NCT ID:
NCT05360758
Status:
UNKNOWN
Last Update Posted:
2022-12-28
First Post:
2022-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ibrutinib Adapted to Response in Patients With CLL
Sponsor:
Grupo Argentino de Tratamiento de la Leucemia Aguda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-27
First Submit QC Date:
None
Study First Post Date:
2022-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-27
Last Update Post Date:
2022-12-28
Last Update Post Date Type:
ACTUAL